News

PharmExec5d
FDA, CDC Recommend Pause on Valneva's Chikungunya Vaccine for Seniors
The decision follows ongoing investigations into serious adverse events primarily reported in elderly individuals who ...
FDA warns seniors to avoid this vaccine after deadly complications
Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...
FDA approves Novavax's COVID-19 vaccine with limitations
The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.
Feds recommend pausing vaccine for mosquito-borne disease chikungunya in people over 60
The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...
Seniors should skip this vaccine after deadly complications, FDA warns
The CDC recommends the vaccine pause while it investigates “serious adverse events,” including neurologic and cardiac events.
Becker's Hospital Review5d
FDA, CDC: Pause chikungunya shots in older adults
The FDA and CDC recommended a pause in administering Ixchiq, a chikungunya vaccine, in adults ages 60 and above after 17 serious adverse events, including two deaths.  About 80,000 Ixchiq doses have ...
Avoid Chikungunya Vaccine If You're Over 60, Say US Health Officials; Here Are The Details
Chikungunya is transmitted to humans through the bite of infected female mosquitoes, particularly Aedes aegypti and Aedes ...
New York Post3d
The vaccine seniors should avoid after deadly complications discovered: FDA
Older adults are being warned against receiving the chikungunya vaccine before traveling. The Ixchiq vaccination, developed by Valneva to prevent the mosquito-borne chikungunya virus, was approved ...
U.S. Advises Older Travelers to Avoid Chikungunya Vaccine
TUESDAY, May 13, 2025 (HealthDay News) — U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya ...